Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule protein polymerization is the dynamic process by which α- and β-tubulin dimers assemble to generate microtubules, a vital component of the eukaryotic cytoskeleton. This process is characterized by "dynamic instability", allowing microtubules to rapidly switch between growth and shrinkage. It is crucial for cell division, intracellular transport, and maintaining cell architecture. Many anticancer drugs target microtubule polymerization to halt cell proliferation[2][3][6][7]. Rather than a distinct molecular entity, microtubule protein polymerization refers to the activity and behavior of tubulin polymers modulated by specific proteins (such as EB1, CLASP, XMAP215) and regulated by GTP hydrolysis[3][6][1].
Stabilization of microtubules against depolymerization (e.g., paclitaxel) Inhibition/disruption of polymerization (e.g., vincristine, colchicine)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule protein polymerization.